Istari Oncology
Get Full AccessDescription
- Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.
-
Headquarters:430 Davis Drive , Morrisville, North Carolina, United States
More -
Phone Number:
-
Website: http://istarioncology.com
-
Employees:35
-
Revenue:$10 - 50M
-
Legal Name:Istari Oncology
-
Istari Oncology's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Istari Oncology
-
Where are Istari Oncology's Headquarters?
Istari Oncology's Headquarters are in 430 Davis Drive ,Morrisville,North Carolina,United States
-
What is Istari Oncology's official website?
Istari Oncology's official website is http://istarioncology.com
-
What is Istari Oncology's Revenue?
Istari Oncology's revenue is $10 - 50M
-
What is Istari Oncology's NAICS code?
Istari Oncology's NAICS code is 541713
-
How many employees are working in Istari Oncology
Istari Oncology has 35 employees
-
What is Istari Oncology's Industry?
Istari Oncology is in the industry of Biotechnology
-
Who is Istari Oncology's Chief Medical Officer?
Istari Oncology's Chief Medical Officer is Garrett Nichols
-
Who is Istari Oncology's Chief Manufacturing Officer?
Istari Oncology's Chief Manufacturing Officer is Jamie Iudica